CRISTIAN-CATALIN GAVAT

Dr. CRISTIAN-CATALIN GAVAT

Biomedical Sciences Department, Grigore T. Popa University of Medicine and Pharmacy, Iaşi, Romania
orcid
Biomedical Sciences Department, Faculty of Medical Bioengine...

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Liliana RosuLiliana Rosu
Liliana Rosu
CRISTIAN-CATALIN GAVATCRISTIAN-CATALIN GAVAT
CRISTIAN-CATALIN GAVAT
Dan RosuDan Rosu
Dan Rosu
Cristian-Dragos VarganiciCristian-Dragos Varganici
Cristian-Dragos Varganici
FMFanica Mustata
Fanica Mustata
The paper describes the photochemical stability of a commercial triphenodioxazine dye (Reactive Blue_204) linked onto a cotton fabric. Preliminary studies have shown that as a result of irradiation, the dye and its photodegradation products can pass directly onto the skin under conditions that mimic human perspiration and cause side-effects. The cotton dyed fabric was photo irradiated at different time intervals. Standard methods were employed to evaluate the color strength at various levels of pH, temperature, dyeing contact time, and salt concentration. The influence of UV radiation at different doses (λ > 300 nm) on the structural and color modifications of the dyed cotton fabrics was studied. Structural modifications before and after irradiation were compared by applying FTIR, UV–Vis, and near infrared chemical imaging (NIR–CI) techniques. Color modifications were investigated with the CIELAB system. Color differences significantly increased with the irradiation dose. High irradiation doses caused changes in the dye structure.

15 November 2019 in Revista de Chimie
Verified
Journal Article
Open access
CGCostinela Valerica Georgescu
Costinela Valerica Georgescu
CRISTIAN-CATALIN GAVATCRISTIAN-CATALIN GAVAT
CRISTIAN-CATALIN GAVAT
DVDoina Carina Voinescu
Doina Carina Voinescu
Costinela Valerica Georgescu, Cristian Catalin Gavat, Doina Carina Voinescu - Iodometric Quantitative Analysis Method of Ascorbic Acid in Tablets

20 March 2014 in Journal of Materials Science
Verified
Journal Article
Closed access
PDF file
LRLiliana Rosu
Liliana Rosu
Dan RosuDan Rosu
Dan Rosu
CRISTIAN-CATALIN GAVATCRISTIAN-CATALIN GAVAT
CRISTIAN-CATALIN GAVAT
Cristian-Dragos VarganiciCristian-Dragos Varganici
Cristian-Dragos Varganici

15 March 2017 in Revista de Chimie
Verified
Journal Article
Closed access
APAna Maria Pelin
Ana Maria Pelin
CRISTIAN-CATALIN GAVATCRISTIAN-CATALIN GAVAT
CRISTIAN-CATALIN GAVAT
GBGabriela Balan
Gabriela Balan
CGCostinela Valerica Georgescu
Costinela Valerica Georgescu
This study assessed the medication used in type 2 diabetes treatment, depending on the glycaemia level and set out the oral anti-diabetics which are recommended, in three study stages: admission, hospitalization and discharge. Eighty patients were selected and diagnosed with diabetes mellitus 2 type, who were registered in the diabetes and nutrition diseases department within Sf. Apostol Andrei Galati Hospital. They were subjected to a series of laboratory tests: blood count, glycosylated haemoglobin, glycaemia level. It were established main classes of anti-diabetic drugs outpatient used and the main types of anti-diabetic agents administrated to patients requiring hospitalization, compared to high glycaemia values. It was given also, the medication used to normalize blood glucose levels during hospitalization and also at discharge. The biguanides associated with sulphonylureas drugs did not provide an adequate glycaemia control, so insulin must be combined with Metformin to normalize blood glucose levels as soon as possible. Glycaemia control was improved and the hypoglycaemia risk was reduced regarding obese patient undergoing treatment with insulin, to whom biguanides were administered.

5 May 2023 in Materials Proceedings
Verified
Conference Paper
Open access
PDF file
CRISTIAN-CATALIN GAVATCRISTIAN-CATALIN GAVAT
CRISTIAN-CATALIN GAVAT
The absorption spectra of Ketoprofen in the UV domain was plotted using absolute methanol p.a. as a control solvent. The maximum absorption wavelength was determined to be at λ = 254 nm for a ketoprofen solution of 1,4 µg /mL prepared from pure crystalline standard ketoprofen dissolved in methanol p.a. The applied method was the subject of a statistical validation procedure, which consisted in completion of the following stages: the linearity of the method studied over the entire chosen concentration range 2.0 μg / mL - 80.0 μg / mL; detection limit (LD), quantitation limit (LQ), Sandell’s sensitivity, interference of the excipients, stability of prepared standard solutions, method and system precision and accuracy of this method. All statistical parameters were within the normal limits. This analysis method has been statistically validated and can be used anytime and anywhere for UV Ketoprofen spectrophotometric assay in a wide range of samples. The amount of pure ketoprofen assigned on the pharmaceutical tablet was found to be 146.326 mg ketoprofen / tablet. This value was very close to the official declared content of the active substance (150 mg pure ketoprofen/ tablet) set by the official pharmaceutical company, with an average percentage deviation of only 2,45% from the official declared pure content . This calculated value (2,45%) was situated below the maximum percentage error from the official content. of declared active substance (± 5%) imposed by official Pharmacopoeias. So, the pharmaceutical product fully respects the normal official limits provided by the Romanian Pharmacopoeia, 10th Edition and also by the European and International Pharmacopoeias rules. Keywords: main objectives; spectrophotometric ultraviolet (UV) method; pure Ketoprofen; quantitative analysis; statistical validation procedure; interference of the excipients; detection limit; quantitation limit
1

3 January 2024 in ScienceOpen Preprints
Verified
Preprint
Open access
CRISTIAN-CATALIN GAVATCRISTIAN-CATALIN GAVAT
CRISTIAN-CATALIN GAVAT
The aim of this research was to exactly quantify pure sodium metamizole from tablets , using a brand new and developed spectrophotometric analysis method in Visible range (VIS). Main objectives consisted in comparing Sodium Metamizole found content with the stated amount of pure active substance declared by pharmaceutical company, according to the official rules of Romanian, European and International Pharmacopoeias. The method applied has been subjected to a validation protocal which consisted in the analysis of the following parameters: linearity of the method, detection limit (LD) , quantitation limit (LQ), Sandel’s sensitivity, interference of excipients, stability of prepared solutions, method and system precision, accuracy of the proposed method. Following actual dosing, pure sodium metamizole amount in tablet of pharmaceutical was found to be 477.477 mg assigned to a percentage content of 95.495 %, very close to official declared amount (500 mg), with an maximum average percentage deviation of only 4.505 % from the official declared active substance content. This value was situated below the maximum admissible percentage deviation from stated active substance content (± 5%), established by European and International Pharmacopoeias and also by Romanian Pharmacopoeia, X-th Edition rules